About Nanosyn
Nanosyn is a company based in Santa Clara (United States) founded in 1998 was acquired by Element Materials Technology in October 2021.. Nanosyn has completed 1 acquisition, including Seres Laboratories. Nanosyn offers products and services including Custom Synthesis, Medicinal Chemistry, Analytical Services, API Process Research, and cGMP Manufacturing. Nanosyn operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others.
- Headquarter Santa Clara, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nanosyn
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$295.3 K (USD), Grant
Jul 01, 2014
-
Investors
Element Materials Technology
& 1 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Element Materials Technology
(Oct 11, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nanosyn
Nanosyn offers a comprehensive portfolio of products and services, including Custom Synthesis, Medicinal Chemistry, Analytical Services, API Process Research, and cGMP Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for synthesizing custom chemicals for drug research.
Designs and optimizes compounds for pharmaceutical applications.
Provides analysis and quality testing for drug compounds.
Develops processes for active pharmaceutical ingredients.
Offers compliant manufacturing for clinical and commercial use.
Funding Insights of Nanosyn
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $295,299
-
First Round
First Round
(01 Feb 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2014 | Amount | Grant - Nanosyn | Valuation |
investors |
|
| Feb, 2013 | Amount | Grant - Nanosyn | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nanosyn
Nanosyn has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Element Materials Technology and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Materials and product testing, inspection, and certification services are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nanosyn
Nanosyn has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Seres Laboratories. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Laboratory services and research are conducted in Santa Rosa.
|
1977 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Nanosyn
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nanosyn Comparisons
Competitors of Nanosyn
Nanosyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, CatSci and NIH, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery and development services are provided to biopharma sector.
|
|
| domain | founded_year | HQ Location |
Cancer and CVMD drugs are developed using PDX models.
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided for therapeutic development.
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided to pharmaceutical clients worldwide.
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided to the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Nanosyn
When was Nanosyn founded?
Nanosyn was founded in 1998 and raised its 1st funding round 15 years after it was founded.
Where is Nanosyn located?
Nanosyn is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
What does Nanosyn do?
Founded in 1998 and based in Santa Clara, United States, Nanosyn operates as a contract research organization in the drug discovery sector. Focused compound libraries, hit-to-lead optimization, and medicinal chemistry services are provided on demand. Chemistry operations encompass design, synthesis including process chemistry and cGMP manufacturing, and analytical services. Biology efforts include over 500 assays across targets like kinases and GPCRs, often utilizing a proprietary microfluidic platform.
Who are the top competitors of Nanosyn?
Nanosyn's top competitors include Evotec, Crown Bioscience and NIH.
What products or services does Nanosyn offer?
Nanosyn offers Custom Synthesis, Medicinal Chemistry, Analytical Services, API Process Research, and cGMP Manufacturing.
How many acquisitions has Nanosyn made?
Nanosyn has made 1 acquisition, including Seres Laboratories.
Who are Nanosyn's investors?
Nanosyn has 2 investors. Key investors include Element Materials Technology, and HHS.